Literature DB >> 7615276

Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody.

R T Przemioslo1, K E Lundin, L M Sollid, J Nelufer, P J Ciclitira.   

Abstract

The isolation of gliadin specific HLA-DQ2 restricted T lymphocyte clones from the intestinal mucosa of patients with coeliac disease supports a role for cell mediated immunity in the pathogenesis of this condition. Whether supernatants from immune activated T cell clones could produce histological damage to duodenal mucosa in vitro was studied. Biopsy specimens were obtained from 18 patients without coeliac disease or any other demonstrable abnormality. The tissue was maintained in organ culture for 24 hours with organ culture medium alone, with supernatant from gliadin sensitive T cell clones that had (B) or had not (A) been stimulated with gluten, and compared with the effects caused by the addition of interferon gamma to the organ culture medium. Both the (B) supernatants (1:100) and interferon gamma (100 IU/ml) produced a significant reduction in the enterocyte height (21:5 (3.4) microns and 21.0 (3.2) microns respectively, each p < 0.001) compared with specimens grown in organ culture medium alone (27.3 (2.8) microns). The toxic effects of (B) supernatants could be blocked by pre-incubating them with anti-interferon gamma antibody. These findings support the role of gliadin sensitive T lymphocytes in the immune pathogenesis of coeliac disease and their secretion of interferon gamma may cause the damage to enterocytes observed in this condition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615276      PMCID: PMC1382625          DOI: 10.1136/gut.36.6.874

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers.

Authors:  A H Stolpen; E C Guinan; W Fiers; J S Pober
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

2.  Biological effects of gamma-interferon on human tumor cells: quantity and affinity of cell membrane receptors for gamma-IFN in relation to growth inhibition and induction of HLA-DR expression.

Authors:  U Ucer; H Bartsch; P Scheurich; K Pfizenmaier
Journal:  Int J Cancer       Date:  1985-07-15       Impact factor: 7.396

3.  Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors.

Authors:  J E Talmadge; O Bowersox; H Tribble; S H Lee; H M Shepard; D Liggitt
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

4.  Gluten sensitivity of small intestinal mucosa in vitro: quantitative assessment of histologic change.

Authors:  P D Howdle; G R Corazza; A W Bullen; M S Losowsky
Journal:  Gastroenterology       Date:  1981-03       Impact factor: 22.682

5.  GVHR elicited by products of class I or class II loci of the MHC: analysis of the response of mouse T lymphocytes to products of class I and class II loci of the MHC in correlation with GVHR-induced mortality, medullary aplasia, and enteropathy.

Authors:  P F Piguet
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

6.  Morphological and morphometric assessment of human duodenal biopsies maintained in organ culture. In vitro influences of gluten in coeliac disease.

Authors:  G Fluge; L Aksnes
Journal:  Scand J Gastroenterol       Date:  1981       Impact factor: 2.423

7.  Organ culture of mucosal biopsies of human small intestine.

Authors:  T H Browning; J S Trier
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

8.  Gut injury in mouse graft-versus-host reaction. Study of its occurrence and mechanisms.

Authors:  D Guy-Grand; P Vassalli
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

9.  Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor alpha in coeliac disease mucosa detected by immunohistochemistry.

Authors:  R T Przemioslo; M Kontakou; V Nobili; P J Ciclitira
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

10.  Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line.

Authors:  L M Sollid; G Gaudernack; G Markussen; D Kvale; P Brandtzaeg; E Thorsby
Journal:  Scand J Immunol       Date:  1987-02       Impact factor: 3.487

View more
  34 in total

Review 1.  Pathogenesis of coeliac disease: implications for treatment.

Authors:  J S Fraser; P J Ciclitira
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

Review 2.  Ages of celiac disease: from changing environment to improved diagnostics.

Authors:  Alberto Tommasini; Tarcisio Not; Alessandro Ventura
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

Review 3.  Cutting-edge issues in celiac disease and in gluten intolerance.

Authors:  N Bizzaro; R Tozzoli; D Villalta; M Fabris; E Tonutti
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

4.  The sourdough fermentation may enhance the recovery from intestinal inflammation of coeliac patients at the early stage of the gluten-free diet.

Authors:  Maria Calasso; Olimpia Vincentini; Francesco Valitutti; Cristina Felli; Marco Gobbetti; Raffaella Di Cagno
Journal:  Eur J Nutr       Date:  2012-02-04       Impact factor: 5.614

Review 5.  Celiac disease: pathogenesis of a model immunogenetic disease.

Authors:  Martin F Kagnoff
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

6.  Analysis of interleukin-4 and interleukin-10 and their association with the lymphocytic infiltrate in the small intestine of patients with coeliac disease.

Authors:  C G Beckett; D Dell'Olio; M Kontakou; R T Przemioslo; S Rosen-Bronson; P J Ciclitira
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

7.  Identification of common epitopes on gliadin, enterocytes, and calreticulin recognised by antigliadin antibodies of patients with coeliac disease.

Authors:  S Krupicková; L Tucková; Z Flegelová; M Michalak; J R Walters; A Whelan; J Harries; J Vencovský; H Tlaskalová-Hogenová
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

Review 8.  Effector and suppressor T cells in celiac disease.

Authors:  Giuseppe Mazzarella
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

9.  Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease.

Authors:  A Di Sabatino; R Ciccocioppo; F Cupelli; B Cinque; D Millimaggi; M M Clarkson; M Paulli; M G Cifone; G R Corazza
Journal:  Gut       Date:  2005-08-16       Impact factor: 23.059

10.  Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides.

Authors:  Michael T Bethune; Matthew Siegel; Samuel Howles-Banerji; Chaitan Khosla
Journal:  J Pharmacol Exp Ther       Date:  2009-02-13       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.